Virology, Nebraska Center for



Kevin Robertson, University of North CarolinaFollow
Jeff Liner, University of North Carolina
James Hakim, University of Zimbabwe
Jean-Louis Sankalé, Globomics
Igor Grant, University of California - San DiegoFollow
Scott Letendre, University of California - San DiegoFollow
David Clifford, Washington University School of MedicineFollow
Amadou Gallo Diop, University of Dakar
Assan Jaye, Medical Research Council Laboratories
Georgette Kanmogne, University of Nebraska Medical CenterFollow
Alfred Njamnshi, University of YaoundéFollow
T. Dianne Langford, Temple University School of MedicineFollow
Tufa Gemechu Weyessa, Addis Ababa University
Charles Wood, University of Nebraska-LincolnFollow
Mwanza Banda, University Teaching Hospital
Mina Hosseinipour, UNC ProjectFollow
Ned Sacktor, Johns Hopkins UniversityFollow
Noeline Nakasuja, Makerere University
Paul Bangirana, Makerere UniversityFollow
Robert Paul, University of MissouriFollow
John Joska, University of Cape TownFollow
Joseph Wong, University of California - San FranciscoFollow
Michael Boivin, Michigan State UniversityFollow
Penny Holding, Case Western Reserve UniversityFollow
Betsy Kammerer, Children’s Hospital, Boston/Harvard Medical SchoolFollow
Annelies Van Rie, University of North Carolina at Chapel HillFollow
Prudence Ive, Clinical HIV Research UnitFollow
Avindra Nath, Johns Hopkins UniversityFollow
Kathy Lawler, University of PennsylvaniaFollow
Clement Adebamowo, Institute of Human VirologyFollow
Walter Royal III, University of Maryland School of MedicineFollow
Jeymohan Joseph, National Institute of Mental HealthFollow

Date of this Version



Journal of NeuroVirology (2010) 16, 189–202.


In July 2009, the Center for Mental Health Research on AIDS at the National Institute of Mental Health organized and supported the meeting “NeuroAIDS in Africa.” This meeting was held in Cape Town, South Africa, and was affiliated with the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Presentations began with an overview of the epidemiology of HIV in sub-Saharan Africa, the molecular epidemiology of HIV, HIV-associated neurocognitive disorders (HANDs), and HAND treatment. These introductory talks were followed by presentations on HAND research and clinical care in Botswana, Cameroon, Ethiopia, The Gambia, Kenya, Malawi, Nigeria, Senegal, South Africa, Uganda, and Zambia. Topics discussed included best practices for assessing neurocognitive disorders, patterns of central nervous system (CNS) involvement in the region, subtype-associated risk for HAND, pediatric HIV assessments and neurodevelopment, HIV-associated CNS opportunistic infections and immune reconstitution syndrome, the evolving changes in treatment implementation, and various opportunities and strategies for NeuroAIDS research and capacity building in the region